Table 3.
Reference | Number of patients | Study type | Article location | Mean age (years) | Patient characteristics | Primary and secondary goal of study |
---|---|---|---|---|---|---|
Positive association studies | ||||||
Filippou et al. [23] | 6 | Prospective observational | Meeting abstract | Unknown | Severe TBI |
Primary: CMD measures and MRS/ADC imaging Secondary: None stated |
Marcoux et al. [53] | 15 | Retrospective case series | Manuscript | 30.1 years (range, 18–58) | Severe TBI |
Primary: Determine association between CMD-based metabolic dysfunction and long-term tissue atrophy Secondary: Determine association with long-term outcome |
Nil association studies | ||||||
Filippou et al. [22] | 10 | Prospective observational | Meeting abstract | Unknown | Severe TBI |
Primary: Determine CMD measure correlation to MRS/ADC Secondary: None mentioned |
Stein et al. [89] | 21 | Prospective observational | Meeting abstract | Unknown | Severe TBI | Primary: To determine if CMD defined metabolic crisis (LPR > 25; glucose <0.8 mmol/l) correlates with MRI-based ADC changes |
TBI traumatic brain injury, CMD cerebral microdialysis, LPR lactate:pyruvate ratio, MRS magnetic resonance spectroscopy, MRI magnetic resonance imaging, ADC apparent diffusion coefficient